Jonathan Violin's Net Worth

$15.8 Million

Estimate Recalculated Sep 18, 2024 09:39PM EST

Who is Jonathan Violin

Jonathan Violin has an estimated net worth of $15.8 Million. This is based on reported shares across multiple companies, which include MIRAGEN THERAPEUTICS, INC., TREVENA INC, Astria Therapeutics, Inc., and Dianthus Therapeutics, Inc. /DE/.

SEC CIK

Jonathan Violin's CIK is 0001730615

Past Insider Trading and Trends

2021 was Jonathan Violin's most active year for acquiring shares with 5 total transactions. Jonathan Violin's most active month to acquire stocks was the month of May. 2022 was Jonathan Violin's most active year for disposing of shares, totalling 9 transactions. Jonathan Violin's most active month to dispose stocks was the month of January. 2023 saw Jonathan Violin paying a total of $7,500.00 for 70,600 shares, this is the most they've acquired in one year. In 2023 Jonathan Violin cashed out on 150,000 shares for a total of $3,680,000.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Viridian Therapeutics, Inc.\DE

Chief Executive Officer
Updated Feb 07, 2023
Form 4/A
-6.49%
-50.00K
$18.47
-$1.83M
Feb 07, 2023
720.11K
Sale
ScheduledFeb 02
Form 4
-10.40%
-50.00K
$36.80
-$1.84M
Feb 03, 2023
430.91K
Sale
ScheduledFeb 02
Form 4
-5.87%
-30.00K
$12.20
-$366.00K
Jun 02, 2022
480.91K
Sale
ScheduledJun 01
Form 4
-5.55%
-30.00K
$13.04
-$391.20K
May 04, 2022
510.91K
Sale
ScheduledMay 02
Form 4
-5.25%
-30.00K
$18.92
-$567.64K
Apr 05, 2022
540.91K
Sale
ScheduledApr 01 - Apr 04
Form 4
-4.99%
-30.00K
$17.65
-$529.49K
Mar 03, 2022
570.91K
Sale
ScheduledMar 01 - Mar 02
Form 4
39.63%
250.00K
$19.09
-$572.82K
Feb 03, 2022
880.91K
Grant
ScheduledFeb 01 - Feb 03
Form 4
4,846.72%
618.15K
Dec 10, 2021
630.91K
Options
Dec 08
Form 4
800.08K
Jan 20, 2021
800.08K
Grant
Jan 18
Form 4
4.40M
Oct 30, 2020
4.40M
Acq/Dis
Oct 27
Form 3
Oct 30, 2020
50.12K
Showing 11 results

TREVENA INC

SVP-Scientific Affairs & IR
Updated Mar 02, 2018
Form 4
140.00K
Mar 02, 2018
140.00K
Grant
Feb 28
Form 3
Feb 08, 2018
10.19K
Showing 2 results

Astria Therapeutics, Inc.

Investor
Updated Jun 06, 2024
Form 4
14.10K
Jun 06, 2024
14.10K
Grant
Jun 05
Form 4
14.10K
Jun 06, 2023
14.10K
Grant
Jun 02
Form 4/A
8.33K
Jun 21, 2022
8.33K
Grant
Jun 09
Form 4
8.33K
Jun 09, 2022
8.33K
Grant
Jun 09
Form 4
Sep 22, 2021
263.32K
Acq/Dis
Sep 20
Form 4
85.00K
Jun 02, 2021
85.00K
Grant
Jun 02
Form 4
15.00K
Feb 01, 2021
15.00K
Grant
Jan 28
Form 3
Feb 01, 2021
543.37K
Showing 8 results

Dianthus Therapeutics, Inc. /DE/

Investor
Updated May 28, 2024
Form 4
11.00K
May 28, 2024
11.00K
Grant
May 23
Form 4
6.50K
Sep 13, 2023
6.50K
Grant
Sep 11
Form 3
Sep 13, 2023
Showing 3 results